Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 742

1.

[Prostate cancer. Treatment].

Fournier G, Valeri A, Mangin P, Cussenot O.

Ann Urol (Paris). 2004 Oct;38(5):225-58. Review. French.

PMID:
15570706
[PubMed - indexed for MEDLINE]
2.

Endocrine treatment of prostate cancer.

Tammela T.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Epub 2004 Dec 31. Review.

PMID:
15663992
[PubMed - indexed for MEDLINE]
3.

Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer.

See WA.

Curr Treat Options Oncol. 2003 Oct;4(5):351-62. Review.

PMID:
12941195
[PubMed - indexed for MEDLINE]
4.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
5.

[Treatment of metastatic prostate cancer: certainty and doubts].

Fournier G, Valéri A.

Presse Med. 1998 Dec 5;27(38):1996-2002. French.

PMID:
9879324
[PubMed - indexed for MEDLINE]
6.

Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.

Aus G.

Scand J Urol Nephrol Suppl. 1994;167:1-41.

PMID:
7542397
[PubMed - indexed for MEDLINE]
7.

[Treatment of metastatic cancer of the prostate].

Fournier G, Mangin P.

Presse Med. 1995 Oct 28;24(32):1465-70. Review. French.

PMID:
8545343
[PubMed - indexed for MEDLINE]
8.

A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.

Hachiya T, Akakura K, Saito S, Shinohara N, Sato K, Harada M, Kato T, Okada K.

BJU Int. 2005 Mar;95(4):534-40.

PMID:
15705075
[PubMed - indexed for MEDLINE]
9.

Medical therapy of prostate cancer. A review.

Roscigno M, Sangalli M, Mazzoccoli B, Scattoni V, Da Pozzo L, Rigatti P.

Minerva Urol Nefrol. 2005 Jun;57(2):71-84. Review.

PMID:
15951731
[PubMed - indexed for MEDLINE]
10.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

Cancer. 2006 Apr 15;106(8):1708-14.

PMID:
16544313
[PubMed - indexed for MEDLINE]
Free Article
11.

[GnRH analogs and prostate cancer treatment].

Zerbib M.

Ann Urol (Paris). 2005 Oct;39 Suppl 3:S66-72. Review. French.

PMID:
16302714
[PubMed - indexed for MEDLINE]
12.

Prostate cancer, Incidence, management and outcomes.

Small EJ.

Drugs Aging. 1998 Jul;13(1):71-81. Review.

PMID:
9679210
[PubMed - indexed for MEDLINE]
13.

Early outcomes of active surveillance for localized prostate cancer.

Hardie C, Parker C, Norman A, Eeles R, Horwich A, Huddart R, Dearnaley D.

BJU Int. 2005 May;95(7):956-60.

PMID:
15839912
[PubMed - indexed for MEDLINE]
14.

[Prostate cancer: Diagnosis and staging].

Fournier G, Valeri A, Mangin P, Cussenot O.

Ann Urol (Paris). 2004 Oct;38(5):207-24. Review. French.

PMID:
15570705
[PubMed - indexed for MEDLINE]
15.

Recent advances in the treatment of prostate cancer.

Kuyu H, Lee WR, Bare R, Hall MC, Torti FM.

Ann Oncol. 1999 Aug;10(8):891-8. Review.

PMID:
10509148
[PubMed - indexed for MEDLINE]
Free Article
16.

Combined androgen blockade: the gold standard for metastatic prostate cancer.

McLeod DG, Crawford ED, DeAntoni EP.

Eur Urol. 1997;32 Suppl 3:70-7. Review.

PMID:
9267789
[PubMed - indexed for MEDLINE]
17.

Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.

Miller N, Smolkin ME, Bissonette E, Theodorescu D.

Cancer. 2005 Jun 15;103(12):2499-506.

PMID:
15852361
[PubMed - indexed for MEDLINE]
Free Article
18.

[Practice guideline 'Prostate cancer: diagnosis and treatment'].

de Reijke TM, Battermann JJ, van Moorselaar RJ, de Jong IJ, Visser AP, Burgers JS.

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1771-5. Review. Dutch.

PMID:
18754308
[PubMed - indexed for MEDLINE]
19.

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.

Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW.

J Endourol. 2007 Dec;21(12):1521-31. doi: 10.1089/end.2007.9875.

PMID:
18186694
[PubMed - indexed for MEDLINE]
20.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk